CAMP

CAMP4 Therapeutics Corporation$4.08-0.17 (-4.00%)

Prev Close$4.25·MCap$94.3M·P/E—·Vol123.4K·Yield—

▲

Buys (12M)

$99.1K

▼

Sells (12M)

$2.50M

◆

Net Activity

Net Seller

$2.40M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at CAMP4 Therapeutics Corporation (CAMP) has been dominated by selling, with 5 insider purchases totaling $99.1K and 4 insider sales totaling $2.50M. The most recent insider transaction was by Gold Kelly (officer: Chief Financial Officer), who purchased $39.6K worth of shares on Sep 2, 2026. CAMP4 Therapeutics Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $94.3M.

CAMP Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 2, 2026	Gold Kelly	officer: Chief Financial Officer	Buy	10,000	$3.96	$39.6K	10,000
Aug 31, 2026	Schwab Andrew J.	director	Sell	400,000	$4.04	$1.62M1.9% OS	2,033,270
Aug 26, 2026	Schwab Andrew J.	director	Sell	10	$4.50	$45.00	2,433,270
Aug 21, 2026	Schwab Andrew J.	director	Sell	191,865	$4.59	$879.7K0.9% OS	2,579,998
Aug 19, 2026	Tardiff Daniel	officer: Chief Scientific Officer	Sell	1,738	$4.76	$8.3K	0Exit
Aug 5, 2026	Mandel-Brehm Josh	director, officer: Chief Executive Officer	Buy	6,551	$1.65	$10.8K	284,968
Aug 5, 2026	Young Richard A	director	Buy	16,378	$1.65	$27.0K	186,388
Aug 5, 2026	Maricich Yuri	officer: Chief Medical Officer	Buy	6,551	$1.65	$10.8K	12,611+108%
Aug 5, 2026	Gold Kelly	officer: Chief Financial Officer	Buy	6,551	$1.65	$10.8K	74,428
Sep 11, 2025	Maricich Yuri	Chief Medical Officer	Buy	6,060	$1.65	$10.0K	0
Sep 11, 2025	Nashat Amir	Director	Buy	1,307,189	$1.53	$2.00M6.2% OS	0
Sep 11, 2025	Young Richard A	Director	Buy	15,151	$1.65	$25.0K	0
Oct 15, 2024	Nashat Amir	Director	Buy	909,090	$11.00	$10.00M4.3% OS	0

CAMP Insider Buying Activity

The following table shows recent insider purchases of CAMP4 Therapeutics Corporation (CAMP) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 2, 2026	Gold Kelly	officer: Chief Financial Officer	Buy	10,000	$3.96	$39.6K	10,000
Aug 5, 2026	Mandel-Brehm Josh	director, officer: Chief Executive Officer	Buy	6,551	$1.65	$10.8K	284,968
Aug 5, 2026	Young Richard A	director	Buy	16,378	$1.65	$27.0K	186,388
Aug 5, 2026	Maricich Yuri	officer: Chief Medical Officer	Buy	6,551	$1.65	$10.8K	12,611+108%
Aug 5, 2026	Gold Kelly	officer: Chief Financial Officer	Buy	6,551	$1.65	$10.8K	74,428
Sep 11, 2025	Maricich Yuri	Chief Medical Officer	Buy	6,060	$1.65	$10.0K	0
Sep 11, 2025	Nashat Amir	Director	Buy	1,307,189	$1.53	$2.00M6.2% OS	0
Sep 11, 2025	Young Richard A	Director	Buy	15,151	$1.65	$25.0K	0
Oct 15, 2024	Nashat Amir	Director	Buy	909,090	$11.00	$10.00M4.3% OS	0

CAMP Insider Selling Activity

The following table shows recent insider sales of CAMP4 Therapeutics Corporation (CAMP) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 31, 2026	Schwab Andrew J.	director	Sell	400,000	$4.04	$1.62M1.9% OS	2,033,270
Aug 26, 2026	Schwab Andrew J.	director	Sell	10	$4.50	$45.00	2,433,270
Aug 21, 2026	Schwab Andrew J.	director	Sell	191,865	$4.59	$879.7K0.9% OS	2,579,998
Aug 19, 2026	Tardiff Daniel	officer: Chief Scientific Officer	Sell	1,738	$4.76	$8.3K	0Exit